References
- BaghdasarianSBHellerGVThe role of myocardial perfusion imaging in the diagnosis of patients with coronary artery disease: developments over the past yearCurr Opin Cardiol2005203697416093754
- BelardinelliLShryockJCRubleJBinding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranesCirc Res1996791153608943953
- CerqueiraMDThe future of pharmacologic stress: selective A2A adenosine receptor agonistsAm J Cardiol20049433D40D 472226
- CerqueiraMDVeraniMSSchwaigerMSafety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial RegistryJ Am Coll Cardiol19942338498294691
- CV Therapeutics IncAstellas and CV’s regadenoson comparable to Adenoscan in heart imaging study2005a810 press release
- CV Therapeutics IncRegadenoson Phase 3 Data Presented as Late-Breaker at American Society of Nuclear Cardiology2005b102 press release
- HendelRCMahmarianJJBatemanTMInitial results regarding safety, tolerability, and hemodynamic effects of CVT-3146, a Selective Adenosine A2A receptor agonist, in patients undergoing pharmacologic stress SPECT myocardial perfusion imagingJ Am Coll Cardiol200443367A abstract
- HendelRCMahmarianJJCerqueiraMDPharmocologic stress SPECT myocardial perfusion imaging with a selective A2A agonist: results of a pilot study comparing adenosine with CVT-3146Circulation200310817 abstract12821552
- GaoZOteroDHZablockiJAPharmacological characterization of novel A2A adenosine receptor (A2AAdoR) agonistsDrug Dev Res20005093
- KerenskyRAvon MeringGOKentKMDose dependent increase in human coronary blood flow velocity after an iv bolus of CVT-3146, a novel A2A adenosine receptor agonist: a potential agent for the use in pharmacological stress testing for myocardial perfusion imagingCirculation2002106618 abstract
- PalleVElzeinEGotheSADesign, synthesis and pharmacological evaluation of 2 (1-alkyl-pyrazol-4-yl) adenosine derivatives as short acting adenosine A2A receptor agonistsDrug Dev Research20005064
- PalleVPElzeinEOGotheSAStructure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptorBioorg Med Chem Lett2002122935912270178
- RanhoskyAKempthorne-RawsonJIntravenous Dipyridamole Thallium Imaging Study GroupThe safety of intravenous dipyridamole thallium myocardial perfusion imagingCirculation199081120592107985
- ZablockiJPalleVBlackburnBNovel short acting coronary vasodilators that are functionally selective for the A2A receptor based on 2-heterocyclic substituted adenosine derivativesDrug Dev Res20005063
- ZablockiJPalleVBlackburnB2-substituted pi system derivatives of adenosine that are coronary vasodilators acting via the A2A adenosine receptorNucleosides Nucleotides Nucleic Acids2001203436011563047